Racette, Brad A <br/><br/>
[18F]FDOPA PET and clinical features in parkinsonism due to manganism.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Apr 2005 
 - 492-496 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/mds.20381  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiparkinson Agents--therapeutic use<br/>Brain--metabolism<br/>Carbidopa--therapeutic use<br/>Drug Combinations<br/>Female<br/>Fluorodeoxyglucose F18<br/>Gait<br/>Humans<br/>Levodopa--therapeutic use<br/>Magnetic Resonance Imaging<br/>Manganese Poisoning--blood<br/>Middle Aged<br/>Parkinson Disease--drug therapy<br/>Positron-Emission Tomography<br/>Radiopharmaceuticals